Study Stopped
Due to the changed standard regarding access for liver transplantation, this no longer complied with the requirements of the study protocol.
Ventral Hernia Prevention After Liver Transplantation
1 other identifier
interventional
36
1 country
1
Brief Summary
This study aims to evaluate if the risk of developing ventral hernia after liver transplantation can be reduced through the prophylactic implantation of a synthetic, fully resorbable mesh "Phasix" in the course of liver transplantation. Patients will be randomized in a 1:1 ratio to receive either Phasix mesh or standard surgery without the use of Phasix. Ultra-sound examinations of the wound area will be performed 14 days, 3, 6 and 12 months after liver transplantation. Furthermore, presence of infections, seroma, pain and other problems in the wound area will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2017
CompletedFirst Posted
Study publicly available on registry
July 19, 2017
CompletedStudy Start
First participant enrolled
November 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 4, 2023
CompletedJanuary 27, 2025
January 1, 2025
5.9 years
July 17, 2017
January 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of ventral hernia
Evaluated by ultra-sound imaging
12 months after liver transplantation
Secondary Outcomes (4)
Infections
12 months after liver transplantation
Wound healing disorders
12 months after liver transplantation
Seroma
12 months after liver transplantation
Hematoma
12 months after liver transplantation
Study Arms (2)
Phasix mesh
EXPERIMENTALPhasix mesh will be affixed to the exposed fascia after closure of the Abdomen in the course of liver transplantation.
Standard surgery
NO INTERVENTIONSurgery will be performed according to routine, without the use of Phasix mesh.
Interventions
After the closure of the Abdomen, Phasix mesh will be placed and affixed on the exposed fascia.
Eligibility Criteria
You may qualify if:
- Age \>18 years
- First transplantation
- Signed Informed Consent
You may not qualify if:
- Combined transplantation
- Revisions after liver transplantation
- Patients who already received laparotomy or transverse upper laparotomy (longer than 15 cm)
- Preexisting abdominal wall hernia except umbilical hernia after liver transplantation
- Pregnant/lactating women
- Known allergies to tetracycline hydrochloride and kanamycin sulfate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Graz; Klin. Abteilung für Transplantationschirurgie
Graz, 8036, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2017
First Posted
July 19, 2017
Study Start
November 30, 2017
Primary Completion
November 4, 2023
Study Completion
November 4, 2023
Last Updated
January 27, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share